{"id":7,"date":"2016-01-29T10:13:23","date_gmt":"2016-01-29T10:13:23","guid":{"rendered":"https:\/\/the7.io\/beauty-studio\/?page_id=7"},"modified":"2025-09-18T12:33:29","modified_gmt":"2025-09-18T10:33:29","slug":"programme","status":"publish","type":"page","link":"https:\/\/www.esptcongress.org\/index.php\/programme\/","title":{"rendered":"Programme"},"content":{"rendered":"

[vc_row css=”.vc_custom_1680534997831{margin-top: 80px !important;margin-bottom: 80px !important;}”][vc_column][vc_accordion active_tab=”” collapsible=”yes” style=”2″][vc_accordion_tab title=”Day 1″]

<\/div>

WEDNESDAY November 5<\/h2><\/div><\/div>
    \n
  • From 07.30 REGISTRATIONS OPEN<\/strong><\/li>\n
  • 09:00 – 11:00 Zaal 3 – ESPT Executive Board meeting \u2013 Closed Meeting<\/li>\n
  • 09:00 – 12:00 Zaal 4 – NVKC \/ CMBD Symposium (in Dutch)<\/li>\n
  • 09:00 – 12:00 Zaal 5 – Apothekers\/Huisartsen Symposium (in Dutch)<\/li>\n
  • 11:00 – 12:00 Zaal 3 – ESPT GENERAL ASSEMBLY – Closed Meeting<\/li>\n
  • 13:00 – 13:30 OPENING of the CONGRESS<\/strong>
    \nWillem Burger Zaal – Plenary
    \nWelcome – Ron van Schaik – Local Organizer
    \nOpening – Mikko Niemi – ESPT President
    \nWelcome – Tomris Ozben – IFCC President
    \nWelcome – Stefan Sleijfer – Dean Erasmus MC \u2013 University Medical Center Rotterdam<\/li>\n
  • 13:30 – 15:20 SESSION 01: CLINICAL IMPLEMENTATION<\/strong>
    \nWillem Burger Zaal
    \nChairs: Ron van Schaik & Jesse Swen
    \n13:30 Implementation of PGx in the UK: a perspective – Sir Munir Pirmohamed
    \n(Keynote Lecture)
    \n13:55 Large scale Pharmacogenomics and Genomics England – Matt Brown
    \n14:20 Universal clinical implementation of PGx in Spain: results of pilot study in
    \npublic healthcare – Adrian Llerena
    \n14:45 Implementaton of PGx in The Netherlands: beyond PREPARE – Jesse Swen
    \n15:10 Abstract: Cost Effectiveness of the PREPARE study – Christina Mitropoulos<\/li>\n
  • 15:20 – 15:50 TEA & COFFEE BREAK and POSTERS VIEWING<\/strong><\/li>\n
  • 15:50 – 17:15 SESSION 02: PSYCHIATRY<\/strong>
    \nWillem Burger Zaal
    \nChairs: Adrian Llerena & Birgit Koch
    \n15:50 Complementary use of PGx and TDM in antidepressive treatment –
    \nEspen Molden
    \n16:15 Integration of PGx in psychiatry: experiences from Canada – Daniel Mueller
    \n16:40 Genome-guided therapeutics in psychiatry: results from the PREPARE
    \nstudy and beyond – George Patrinos
    \n17:05 Abstract: The Dutch P4CARE PGx implementation study for primary care –
    \nJesse Swen & Ron van Schaik
    \n17:15 END of the day<\/li>\n
  • From 17:30 OPENING RECEPTION at CITY HALL<\/strong><\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 2″]
    <\/div>

    THURSDAY November 6<\/h2><\/div><\/div>
      \n
    • From 07.30 REGISTRATIONS OPEN<\/strong><\/li>\n
    • 08:00 – 08.45 Willem Burger Zaal – Corporate Workshop<\/strong>
      \nAgena Bioscience & Platomics
      \nTowards clinical guideline and IVDR compliant pharmacogenetic
      \ntesting. Implementing pharmacogenetic panel solutions for enhanced
      \noutcomes and regulatory adherence – Maaike van der Lee<\/li>\n
    • 08:00 – 08:45 Zaal 3 – Mini Symposium<\/strong>
      \nFinnish Society of Clinical Pharmacology
      \nClinical implementation of PGx in Finland
      \nChair: Mikko Niemi
      \n08:00 Translating Pharmacogenetics into Clinical Practice: Insights from the
      \nFirst 10,000 Patients Genotyped with a 12-Gene Panel – Kaisa Litonius
      \n08:15 Perceptions of the general public and healthcare professionals on
      \npharmacogenetic testing – Noora Kulla
      \n08:30 Implementing DPYD genotyping in Finland: impact on fluoropyrimidine
      \nexposure and safety – Antti Hosio<\/li>\n
    • 08:00 – 08:45 Zaal 4 – Mini Symposium<\/strong>
      \nFrancophone Network of PGx (RNPGx)
      \nUsing pangenomic data in PGx
      \nChair: Nicolas Picard
      \n08:00 WES and PGx: technical challenges and clinical opportunities – Laure
      \nRaymond
      \n08:20 Organizational and regulatory aspects – Louis Lebreton<\/li>\n
    • 09:00 – 10:40 SESSION 03: PEDIATRICS<\/strong>
      \nWillem Burger Zaal
      \nChairs: Marieke Coenen & Mikko Niemi
      \n09:00 Optimal busulfan exposure enhances hematopoietic stem cells
      \ntransplantation outcomes in high-risk pediatric ALL – Marc Ansari
      \n09:25 Genotype-guided asthma treatment reduces exacerbations in children \u2013
      \nAnke-Hilse Maitland-van der Zee
      \n09:50 Reducing aminoglycoside ototoxicity through MT-RNR1 testing –
      \nWilliam Newman
      \n10:15 Pharmacogenomics of anti-TNF drugs in pediatric inflammatory bowel
      \ndisease. From research to clinical implementation? – Luis Andr\u00e9s
      \nL\u00f3pez-Fern\u00e1ndez<\/li>\n
    • 10:40 – 11:10 TEA & COFFEE BREAK and POSTERS VIEWING<\/strong><\/li>\n
    • 11:10 – 13:00 SESSION 04: ONCOLOGY<\/strong>
      \nWillem Burger Zaal
      \nChairs: Ron Mathijssen & Erika Cecchin
      \n11:10 Clinical benefit and utility of DPYD and UGT1A1 testing in gastrointestinal
      \ncancer: beyond single-gene targeted genotyping – Erika Cecchin
      \n11:35 CYP2D6 and tamoxifen: current status – Matthias Schwab
      \n12:00 US FDA and guidelines perspectives on DPYD testing – Daniel Hertz
      \n12:25 New developments in Precision Oncology – Scott Chandler
      \n12:50 Selected abstract<\/li>\n
    • 13:00 – 14:30 WORKING LUNCH \/ POSTERS VIEWING \/ BOOTHS VISITS<\/strong><\/li>\n
    • 14:30 – 16:20 SESSION 05: CARDIOVASCULAR<\/strong>
      \nWillem Burger Zaal
      \nChairs: Mikko Niemi & Mia Wadelius
      \n14:30 Genetics and Precision Medicine in diabetes care – Ewan Pearson
      \n14:55 Pharmacogenetics of statins – Mikko Niemi
      \n15:20 CYP2C19 genotyping in patients undergoing percutaneous coronary
      \nintervention – Jur ten Berg
      \n15:45 CYP2C19 and clopidogrel in ischemic stroke: current status – Bob
      \nRoozenbeek
      \n16:10 Selected abstract<\/li>\n
    • 16:20 – 16:50 TEA & COFFEE BREAK and POSTERS VIEWING<\/strong><\/li>\n
    • 16:50 – 18:15 SESSION 06: SOLID ORGAN TRANSPLANTATION<\/strong>
      \nWillem Burger Zaal
      \nChairs: Teun van Gelder & Nicolas Picard
      \n16:50 Pharmacogenetics in solid organ transplantation: ready for
      \nimplementation? – Teun van Gelder
      \n17:15 Crosstalk between gut microbiome and immunosuppressive drugs in
      \nkidney transplantation – Laure Elens
      \n17:40 Pharmacogenetics in kidney transplantation: from targeted analysis of
      \nimmunosuppressants to the pharmacogenetic passport – Nicolas Picard
      \n18:05 Selected abstract
      \n18:15 END of the day<\/li>\n
    • 20.00 SOCIAL DINNER<\/strong>
      \nLocation: EUROMAST
      \nTickets must be purchased in addition to the registration fee<\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 3″]
      <\/div>

      FRIDAY November 7<\/h2><\/div><\/div>
        \n
      • From 07.30 REGISTRATIONS OPEN<\/strong><\/li>\n
      • 08:00 – 08.45 Willem Burger Zaal – Corporate Workshop<\/strong>
        \nIllumina
        \nClinical Implementation of Pharmacogenomics in the Scottish NHS
        \nAlexander Donay<\/li>\n
      • 08:00 – 08:45 Zaal 3 – Mini Symposium<\/strong>
        \nSpanish Society of Pharmacogenetics and Pharmacogenomics (SEFF)
        \nImplementation of pharmacogenetics in Spain
        \nChair: Cristina Rodr\u00edguez-Antona
        \n08:00 Implementation of the Pharmacogenetic testing catalog of the National
        \nHealthcare System – Xandra Garcia-Gonzalez
        \n08:20 SEFF pharmacogenetics guidelines – Juliana Salazar<\/li>\n
      • 08:00 – 08:45 Zaal 4 – Mini Symposium<\/strong>
        \nItalian Society of Pharmacology (SIF)
        \nChair: Erika Cecchin
        \n08:00 Personalized psychiatry: pharmacogenetic insights – Alessio Squassina
        \n08:15 Integrating pharmacogenetics, drug monitoring and pharmaco-vigilance
        \nfor optimized and safer oral anticancer treatment – Rossana Roncato
        \n08:30 Pharmacogenomics for children: mechanistic insights from studies on
        \nextracellular vesicles – Gabriele Stocco<\/li>\n
      • 09:00 – 10:40 SESSION 07: GLOBAL PERSPECTIVES<\/strong>
        \nWillem Burger Zaal
        \nChairs: Ann Daly & Sanja Stankovic
        \n09:00 PGRN: fostering global awareness of pharmacogenomics – Erica Woodahl (PGRN President – Keynote Lecture)
        \n09:25 Long read sequencing and return of results to biobank participants – Lili Milani
        \n09:50 Bridging the Gap: understanding missing heritability in pharmacogenomics – Magnus Ingelman-Sundberg
        \n10:15 Pharmacogenomic diversity in Latin American populations: Brazil as a model case – Guilherme Suarez-Kurtz<\/li>\n
      • 10:40 – 11:10 TEA & COFFEE BREAK and POSTERS VIEWING<\/strong><\/li>\n
      • 11:10 – 12:50 SESSION 08: LIQUID BIOPSY<\/strong>
        \nWillem Burger Zaal
        \nChairs: Daan van den Broek & Cristina Rodr\u00edguez-Antona
        \n11:10 Liquid biopsy: current state of the art – Klaus Pantel (Keynote Lecture)
        \n11:35 Unraveling the biology of metastasis-competent circulating tumor cells: insights into the metastatic cascade – Catherine Alix Panabieres
        \n12:00 Integrated diagnostics in oncology: bridging tumor markers, liquid biopsy, multi-omics, and imaging: through clinical case studies – Tomris Ozben
        \n12:25 Implementation of ctDNA analysis: COIN initiative – Daan van den Broek<\/li>\n
      • 12:50 – 14:15 WORKING LUNCH \/ POSTERS VIEWING \/ BOOTHS VISITS<\/strong><\/li>\n
      • 14:15 – 15:55 SESSION 09: POPULATION, TECHNICAL AND ETHICAL ASPECTS<\/strong>
        \nWillem Burger Zaal
        \nChairs: Maja Matic & Ingolf Cascorbi
        \n14:15 Genomic Medicine Sweden \u2013 implementing precision medicine at national level – Richard Rosenquist
        \n14:40 Advancing pharmacogenetics testing using long-read sequencing and ONT\u2019s adaptive sampling – Per Hoffmann
        \n15:05 Unlocking clinical value in pharmacogenetic testing: real-life insights from the lab – Robert Akkers
        \n15:30 Ethical aspects of PGx as secondary finding – Martina Cornel<\/li>\n
      • 15:55 – 16:25 TEA & COFFEE BREAK and POSTERS VIEWING<\/strong><\/li>\n
      • 16:25 – 17:40 SESSION 10: DECISION SUPPORT TOOL & ECONOMICAL ASPECTS<\/strong>
        \nWillem Burger Zaal
        \nChairs: Maaike van der Lee & Vita Dolzan
        \n16:25 Association for Molecular Pathology\u2019s Recommendations for clinical pharmacogenotyping allele selection – Vicky Prat
        \n16:50 Advancing personalized medication in primary care through digitalization and pharmacogenetics – Herna Mu\u00f1oz-Galeano
        \n17:15 Economics of pharmacogenetic-guided treatments – Dyfrig Hughes
        \n17:40 ESPT Contribution Award – Mikko Niemi & Ron van Schaik
        \n17:45 END of the day<\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 4″]
        <\/div>

        SATURDAY November 8<\/h2><\/div><\/div>
          \n
        • From 09.00 REGISTRATIONS OPEN<\/strong>
          \n09:00 – 09:30 Willem Burger Zaal<\/strong>
          \nChairs: Birgit Koch & Mikko Niemi
          \nOne test, a life-time of impact: pre-emptive PGx testing in pediatric
          \ncare – Steve J. Melnick and David Mancuso
          \n09:30 Selected abstract
          \n09:40 Selected abstract
          \n09:50 POSTER AWARDS – Chair of Poster Committee<\/li>\n
        • 10:00 – 12:00 DISCUSSION FORUM – How to further implement PGx?<\/strong>
          \nWillem Burger Zaal
          \nChair: Ron van Schaik
          \nTOPICS:
          \n1. Clinical Implementation of Pharmacogenetics across Europe
          \nMunir Pirmohamed (UK), Erika Cecchin (IT), Adrian Llerena (ES), <\/em>Nicolas Picard (FR), Mikko Niemi (FI), Jesse Swen (NL), Mia Wadelius (SE), <\/em>Lili Milani (EE), Steven Melnick (US), Laure Elens (BE)<\/em>
          \n2. Ethical and regulatory aspects
          \nWilliam Newman (UK), Martina Cornel (NL), Daniel Hertz (US), <\/em>Jasmine Gratton (EMA)<\/em>
          \n3. Industry view on PGx developments
          \nClaire Bloor (Thermo Fisher), Vicky Pratt (Agena), Cerissa French (Oxford <\/em>Nanopore), Gino Miele (Gene Drive), Tiffany Morris (Illumina), <\/em>Daniel Langhoff (Eurofins Genomics), Oliver Goldenberg (Roche)<\/em>
          \n4. Which are the needs on PGx research?
          \nMagnus Ingelman-Sundberg (SE), Ingolf Cascorbi (DE), Erica Woodahl (US) <\/em>Teun van Gelder (NL), Alexandra Becker (EP PerMed), Birgit Koch (NL)<\/em><\/li>\n
        • 12:00 END OF THE CONGRESS<\/strong>
          \nPost Conference Lecture for the General Public<\/li>\n
        • 15:00 – 16:00 Studio 8 – Publiekslezing<\/strong>
          \nFarmacogenetica: uw DNA paspoort voor medicatie! Ron van Schaik<\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row][vc_row disable_element=”yes” css=”.vc_custom_1758188970384{margin-top: 80px !important;margin-bottom: 80px !important;}”][vc_column][vc_accordion active_tab=”” collapsible=”yes” style=”2″][vc_accordion_tab title=”Day 1″]
          <\/div>

          WEDNESDAY October 25<\/h2><\/div><\/div>

          12:30 – 14:30 ESPT Executive Board meeting <\/strong>\u2013 Closed Meeting<\/p>\n

          15:00 – 15:45 Meeting with ESPT National Representatives \u2013 Closed Meeting<\/p>\n

          16:00 – 17:00 ESPT General Assembly<\/strong><\/p>\n

          13:00 \u2013 18:00 Pre – Registration<\/p>\n

          18:00 – 19:30 OPENING RECEPTION at the congress venue DGI-Byen<\/p>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 2″]

          <\/div>

          THURSDAY October 26<\/h2><\/div><\/div>
            \n
          • 07.30 Registrations open<\/strong><\/li>\n<\/ul>\n

             <\/p>\n

              \n
            • 08:45 Opening and Welcome<\/strong> – Lona Louring Christrup<\/em><\/li>\n<\/ul>\n

              Welcome – Danish Ministry of Health<\/em><\/p>\n

              Welcome on behalf of ESPT \u2013 Ann Daly<\/em><\/p>\n

               <\/p>\n

                \n
              • SESSION: PGx CLINICAL IMPLEMENTATION <\/strong><\/li>\n<\/ul>\n

                Chairs: Lona Christrup & Ann Daly<\/em><\/strong><\/p>\n

                09:00 A historic overview of pharmacogenetics: Kim Brosen\u2019s perspective – Kim Br\u00f8sen<\/em><\/p>\n

                09:30 Implementing pharmacogenomic panel testing in Europe: experiences from the U-PGx PREPARE study – Jesse Swen<\/em><\/p>\n

                09:55 Pharmacogenomics beyond single common genetic variants: the way forward – Magnus Ingelman-Sundberg<\/em><\/p>\n

                 <\/p>\n

                10:20 – 10:50 COFFEE BREAK<\/strong><\/p>\n

                 <\/p>\n

                  \n
                • SESSION: PSYCHIATRY<\/strong><\/li>\n<\/ul>\n

                  Chairs: Sanja Stankovic & Michael Asger Andersen <\/em><\/strong><\/p>\n

                  10:50 PGx-guided precision dosing of antidepressants – all settled? – Espen Molden<\/em><\/p>\n

                  11:15 Applying PGx in Psychiatry: Taking things personally – Daniel Mueller<\/em><\/p>\n

                  11.40 Real World Pharmacogenetic experience from a Canadian perspective – Ruslan Dorfman<\/em><\/p>\n

                  12:05 Global Diversity Array with enhanced PGx as a method for panel PGx testing: results of a validation study with samples from the PREPARE study \u2013\u00a0Sylvia Klomp<\/i><\/p>\n

                  12:30 Cost-effectiveness of pharmacogenomic-guided treatment: results from a microsimulation model for major depression – Shahzad Ghanbarian<\/em><\/p>\n

                   <\/p>\n

                  12:45 – 13:45 LUNCH \/ POSTER VIEWING \/BOOTH VISITS<\/strong><\/p>\n

                   <\/p>\n

                    \n
                  • SESSION: ONCOLOGY<\/strong><\/li>\n<\/ul>\n

                    Chairs: Mikko Niemi & Niels Westergaard <\/strong><\/em><\/p>\n

                    13:45 DPYD pharmacogenetics: the long and winding road to precision dosing of fluoropyrimidines – Erika Cecchin<\/em><\/p>\n

                    14:10 Addressing phenoconversion with the Geneva phenotyping cocktail: clinical experience – Caroline Samer<\/em><\/p>\n

                    14:35 Drug transporters and novel biomarkers in chemotherapy-induced peripheral neuropathy – Tore Bjerregaard Stage<\/em><\/p>\n

                    15:00 Clinical opportunities for germline pharmacogenetics and management of drug-drug interactions in patients with advanced solid cancers – Vicky Pratt<\/em><\/p>\n

                    15.25 Germline variants are associated with clinical outcomes and pharmacokinetics in patients with ALK+ NSCLC treated with alectinib – Niels Heersche<\/em><\/p>\n

                     <\/p>\n

                    15:40 – 16:10 TEA BREAK\u00a0<\/strong><\/p>\n

                     <\/p>\n

                      \n
                    • SESSION: ctDNA<\/strong><\/li>\n<\/ul>\n

                      Chairs: Ron van Schaik & Vita Dolzan <\/strong><\/em><\/p>\n

                      16:10 Liquid Biopsy: From Discovery to Clinical Implementation – Klaus Pantel (KEYNOTE LECTURE)<\/em><\/p>\n

                      16:40 Circulating Tumor DNA for Minimal Residual Disease Detection and Risk-Stratified Recurrence Surveillance – Claus Lindbjerg Andersen<\/em><\/p>\n

                      17:05 The power of circulating tumor cells in immuno-oncology- Catherine Alix Panabieres<\/em><\/p>\n

                       <\/p>\n

                        \n
                      • 17:30 CLOSURE<\/strong><\/li>\n<\/ul>\n

                         <\/p>\n

                          \n
                        • 20:00 CONGRESS DINNER<\/strong><\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 3″]
                          <\/div>

                          FRIDAY October 27<\/h2><\/div><\/div>
                            \n
                          • SESSION: PGx CHALLENGES<\/strong><\/li>\n<\/ul>\n

                            Chairs: Ron van Schaik & Kim Dahlhoff <\/strong><\/em><\/p>\n

                            08:45 Pharmacogenomics of Adverse Drug Reactions – Sir Munir Pirmohamed KEYNOTE LECTURE<\/em><\/p>\n

                            09:15 The future of PGx testing; lessons from the 100,000 Genomes project – Matt Brown KEYNOTE LECTURE<\/em><\/p>\n

                            09:40 Pharmacogenomics with Rural and Indigenous Communities – Erica Woodahl<\/em><\/p>\n

                             <\/p>\n

                            10:05 – 10:35 COFFEE BREAK\u00a0<\/strong><\/p>\n

                             <\/p>\n

                              \n
                            • SESSION: CARDIOLOGY<\/strong><\/li>\n<\/ul>\n

                              Chairs: Adrian Llerena & Vangelis Manolopoulos <\/strong><\/em><\/p>\n

                              10:35 Impact of Implementing CYP2C19 Genotype Guided Antiplatelet Treatment in Clinical practice – Wout van den Broek<\/em><\/p>\n

                              11:00 Statin pharmacogenetics \u2013 clinical relevance and implementation – Mikko Niemi<\/em><\/p>\n

                              11:25 Pharmaco(epi)genomics of oral anticoagulation therapy with DOACs – Vangelis Manolopoulos<\/em><\/p>\n

                              11:50 Pharmacogenetics in clinical practice, experience and expectations of pharmacogenetic tests \u2013 Marieke Coenen<\/em><\/p>\n

                              12:15 Exploring the Genetic Basis of Dyspnea in Individuals Treated with Ticagrelor – Marc-Olivier Pilon<\/em><\/p>\n

                               <\/p>\n

                              12:30 – 13:30 LUNCH \/ POSTER VIEWING \/BOOTH VISITS\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong><\/p>\n

                               <\/p>\n

                                \n
                              • SESSION: <\/strong><\/strong>PERSONALISING DRUG TREATMENT<\/strong><\/li>\n<\/ul>\n

                                Chairs: Vita Dolzan & Morton Balzer <\/strong><\/em><\/p>\n

                                13:30 Cocktail approach of probe drugs applying GWAS: Further variants of relevance? – Ingolf Cascorbi<\/em><\/p>\n

                                13:55 Clinical scenarios where point of care pharmacogenetic testing improves outcome – William (Bill) Newman<\/em><\/p>\n

                                14:20 OPRA (Oncology Precision Project Aarhus); Pharmacogenomically guided treatment for cancer patients – Britt Elmedal Laursen<\/em><\/p>\n

                                14:45 Identification of DPYD copy number variation in Finnish population using high-throughput next generation sequencing – Sofia Khan<\/em><\/p>\n

                                 <\/p>\n

                                15:00- 15:30 COFFEE BREAK\u00a0<\/strong><\/p>\n

                                 <\/p>\n

                                  \n
                                • SESSION: FOCUS ON THE FUTURE<\/strong><\/li>\n<\/ul>\n

                                  Chairs: Csilla Sipeky & Jon Thor Traerup Andersen <\/strong><\/em><\/p>\n

                                  15:30 Progress at the Danish National Genome Center – Peter Johansen<\/em><\/p>\n

                                  15:55 Using NGS for PGx – Robert Akkers<\/em><\/p>\n

                                  16:20 Clinical Pharmacogenetics Implementation in Spanish Health Service (MedeA, IMPaCTm BiofRAM) – Adrian Llerena<\/em><\/p>\n

                                   <\/p>\n

                                    \n
                                  • 16:45 POSTER PRIZE\u00a0\u00a0\u00a0<\/strong><\/li>\n<\/ul>\n

                                     <\/p>\n

                                      \n
                                    • 17:00 CLOSURE<\/strong><\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][vc_accordion_tab title=”Day 4″]
                                      <\/div>

                                      SATURDAY October 28<\/h2><\/div><\/div>

                                      Discussion Forum: How to move forward with implementing PGx?<\/strong><\/h4>\n
                                        \n
                                      • 9.30 – 10.00 WELCOME COFFEE<\/strong><\/li>\n<\/ul>\n

                                         <\/p>\n

                                          \n
                                        • 10:00 – 10:45 PANEL SESSION 1: IMPLEMENTATION<\/strong><\/li>\n<\/ul>\n

                                          SHORT INTRO: Reflection on implementation of PGx in UK <\/strong><\/p>\n

                                          – Professor Sir Munir Pirmohamed, MD\/PhD<\/em><\/p>\n

                                          – Erika Cecchin – Italy (Oncology)<\/em><\/p>\n

                                          – Britt Elmedah Laursen – Denmark (Oncology) <\/em><\/p>\n

                                          – Adrian Llerena – Spain (PGx-implementation)<\/em><\/p>\n

                                          – Daniel Mueller – Canada (Psychiatry)<\/em><\/p>\n

                                          – William (Bill) Newman – England (Clinical Genetics)<\/em><\/p>\n

                                          –<\/em> Mikko Niemi – Finland (general PGx services)<\/em><\/p>\n

                                          – Jesse Swen –\u00a0The Netherlands (PGx-services)<\/em><\/p>\n

                                           <\/p>\n

                                            \n
                                          • 10:45 – 11:15 PANEL SESSION 2: INDUSTRY VIEW\u00a0<\/strong><\/li>\n<\/ul>\n

                                            SHORT INTRO: PGx in the near future: a laboratory perspective<\/strong><\/p>\n

                                            –<\/em> Daniel Langhoff – Director Eurofins Genomics, Denmark<\/em><\/p>\n

                                            – Ruslan Dorfman – Pillcheck Canada\u00a0<\/em><\/p>\n

                                            – Tiffany Morris – Illumina<\/em><\/p>\n

                                            – Vicky Pratt <\/span>– <\/span>AGENA Bioscience\u00a0<\/em><\/p>\n

                                            – Dominique Dewolf – Thermo Fisher Scientific\u00a0<\/em><\/p>\n

                                             <\/p>\n

                                              \n
                                            • 11:15 – 11:45 PANEL SESSION 3: PGx RESEARCH<\/strong><\/li>\n<\/ul>\n

                                              SHORT INTRO: Which (additional) research is needed?<\/strong><\/p>\n

                                              – <\/em>Magnus Ingelman-Sundberg – Karolinska Instituten, Sweden<\/em><\/p>\n

                                              – Matt Brown –\u00a0Biobank – Genomics England<\/em><\/p>\n

                                              – Kim Brosen, Clinical Pharmacology – Denmark<\/em><\/p>\n

                                              – Ingolf Cascorbi – Clinical Pharmacology – Germany<\/em><\/p>\n

                                               <\/p>\n

                                                \n
                                              • 11.45 CLOSURE + Announcement 2025 ESPT venue<\/strong> – Ann Daly<\/em><\/li>\n<\/ul>\n<\/div>[\/vc_accordion_tab][\/vc_accordion][vc_column_text css=””]PROGRAMMA ROTTERDAM OSCURATO[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

                                                [vc_row css=”.vc_custom_1680534997831{margin-top: 80px !important;margin-bottom: 80px !important;}”][vc_column][vc_accordion active_tab=”” collapsible=”yes” style=”2″][vc_accordion_tab title=”Day 1″][\/vc_accordion_tab][vc_accordion_tab title=”Day 2″][\/vc_accordion_tab][vc_accordion_tab title=”Day 3″][\/vc_accordion_tab][vc_accordion_tab title=”Day 4″][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row][vc_row disable_element=”yes” css=”.vc_custom_1758188970384{margin-top: 80px !important;margin-bottom: 80px !important;}”][vc_column][vc_accordion active_tab=”” collapsible=”yes” style=”2″][vc_accordion_tab title=”Day 1″][\/vc_accordion_tab][vc_accordion_tab title=”Day 2″][\/vc_accordion_tab][vc_accordion_tab title=”Day 3″][\/vc_accordion_tab][vc_accordion_tab title=”Day 4″][\/vc_accordion_tab][\/vc_accordion][vc_column_text css=””]PROGRAMMA ROTTERDAM OSCURATO[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":300,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7","page","type-page","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/pages\/7","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/comments?post=7"}],"version-history":[{"count":20,"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/pages\/7\/revisions"}],"predecessor-version":[{"id":3798,"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/pages\/7\/revisions\/3798"}],"wp:attachment":[{"href":"https:\/\/www.esptcongress.org\/index.php\/wp-json\/wp\/v2\/media?parent=7"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}